Perrigo Net Income 2010-2023 | PRGO
Perrigo net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Perrigo Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-13 |
| 2022 | $-141 |
| 2021 | $-69 |
| 2020 | $-163 |
| 2019 | $146 |
| 2018 | $131 |
| 2017 | $120 |
| 2016 | $-4,013 |
| 2015 | $43 |
| 2015 | $136 |
| 2014 | $233 |
| 2013 | $442 |
| 2012 | $402 |
| 2011 | $339 |
| 2010 | $224 |
| 2009 | $146 |
| Perrigo Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-32 |
| 2023-09-30 | $14 |
| 2023-06-30 | $8 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-24 |
| 2022-09-30 | $-49 |
| 2022-06-30 | $-65 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $10 |
| 2021-09-30 | $-59 |
| 2021-06-30 | $-58 |
| 2021-03-31 | $38 |
| 2020-12-31 | $-175 |
| 2020-09-30 | $-155 |
| 2020-06-30 | $61 |
| 2020-03-31 | $106 |
| 2019-12-31 | $-19 |
| 2019-09-30 | $92 |
| 2019-06-30 | $9 |
| 2019-03-31 | $64 |
| 2018-12-31 | $82 |
| 2018-09-30 | $-68 |
| 2018-06-30 | $36 |
| 2018-03-31 | $81 |
| 2017-12-31 | $73 |
| 2017-09-30 | $45 |
| 2017-06-30 | $-70 |
| 2017-03-31 | $72 |
| 2016-12-31 | $-1,359 |
| 2016-09-30 | $-1,590 |
| 2016-06-30 | $-534 |
| 2016-03-31 | $-529 |
| 2015-12-31 | $-174 |
| 2015-09-30 | $261 |
| 2015-06-30 | $-22 |
| 2015-03-31 | $-22 |
| 2014-12-31 | $70 |
| 2014-09-30 | $96 |
| 2014-06-30 | |
| 2014-03-31 | $48 |
| 2013-12-31 | $-86 |
| 2013-09-30 | $111 |
| 2013-06-30 | |
| 2013-03-31 | $112 |
| 2012-12-31 | $106 |
| 2012-09-30 | $106 |
| 2012-06-30 | |
| 2012-03-31 | $116 |
| 2011-12-31 | $100 |
| 2011-09-30 | $70 |
| 2011-06-30 | |
| 2011-03-31 | $89 |
| 2010-12-31 | $90 |
| 2010-09-30 | $74 |
| 2010-06-30 | |
| 2010-03-31 | $62 |
| 2009-12-31 | $61 |
| 2009-09-30 | $52 |
| 2009-06-30 | |
| 2009-03-31 | $46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.426B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.877B | 24.14 |
| Stryker (SYK) | United States | $128.028B | 30.70 |
| Boston Scientific (BSX) | United States | $107.805B | 33.58 |
| Medtronic (MDT) | Ireland | $106.544B | 15.08 |
| EssilorLuxottica (ESLOY) | France | $97.060B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.204B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.949B | 30.46 |
| ResMed (RMD) | United States | $31.437B | 29.52 |
| Terumo (TRUMY) | Japan | $25.223B | 35.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.713B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $24.656B | 19.10 |
| Baxter (BAX) | United States | $20.501B | 14.95 |
| Insulet (PODD) | United States | $12.040B | 63.21 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.549B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.693B | 22.92 |
| BellRing Brands (BRBR) | United States | $7.226B | 38.85 |
| Haemonetics (HAE) | United States | $4.670B | 23.88 |
| Lantheus Holdings (LNTH) | United States | $4.561B | 11.78 |
| GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.563B | 16.84 |
| Envista Holdings (NVST) | United States | $3.382B | 12.86 |
| Green Thumb Industries (GTBIF) | United States | $3.229B | 102.33 |
| QuidelOrtho (QDEL) | United States | $2.712B | 9.84 |
| Neogen (NEOG) | United States | $2.671B | 25.69 |
| ICU Medical (ICUI) | United States | $2.386B | 17.80 |
| Verano Holdings (VRNOF) | United States | $2.161B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.111B | 683.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.061B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Agios Pharmaceuticals (AGIO) | United States | $1.845B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.491B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.455B | 48.00 |
| InMode (INMD) | Israel | $1.444B | 7.47 |
| National Vision Holdings (EYE) | United States | $1.364B | 42.49 |
| AdaptHealth (AHCO) | United States | $1.309B | 9.85 |
| AtriCure (ATRC) | United States | $1.167B | 0.00 |
| Warby Parker (WRBY) | United States | $1.163B | 0.00 |
| MacroGenics (MGNX) | United States | $0.925B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.857B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.795B | 0.00 |
| Evolus (EOLS) | United States | $0.737B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.65 |
| VAREX IMAGING (VREX) | United States | $0.660B | 14.25 |
| TerrAscend (TSNDF) | Canada | $0.635B | 0.00 |
| Quanterix (QTRX) | United States | $0.617B | 0.00 |
| Jin Medical (ZJYL) | China | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.503B | 0.00 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| ZimVie (ZIMV) | United States | $0.414B | 25.33 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.405B | 6.70 |
| Surmodics (SRDX) | United States | $0.366B | 39.52 |
| Zynex (ZYXI) | United States | $0.353B | 47.70 |
| Viemed Healthcare (VMD) | United States | $0.318B | 31.50 |
| Cerus (CERS) | United States | $0.309B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.263B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.71 |
| Organigram Holdings (OGI) | Canada | $0.219B | 0.00 |
| Veru (VERU) | United States | $0.198B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.171B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.166B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.165B | 83.00 |
| Quipt Home Medical (QIPT) | United States | $0.153B | 0.00 |
| InterCure (INCR) | Israel | $0.133B | 22.46 |
| FitLife Brands (FTLF) | United States | $0.128B | 20.55 |
| MariMed (MRMD) | United States | $0.122B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 8.55 |
| Allurion Technologies (ALUR) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.087B | 0.00 |
| Chimerix (CMRX) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.075B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.47 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.66 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |